Introduction: evidence for the role of the polyol pathway in the pathophysiology of diabetic complications.
Beyer
T A
TA
Hutson
N J
NJ
D000449:Aldehyde Reductase / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D002386:Cataract / Q000188:drug therapy / Q000209:etiology; D003920:Diabetes Mellitus; D004285:Dogs; D005985:Glyceraldehyde / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use; D048289:Imidazolidines; D007064:L-Iditol 2-Dehydrogenase / Q000378:metabolism / Q000502:physiology*; D007908:Lens, Crystalline / Q000201:enzymology; D011817:Rabbits; D051381:Rats; D013401:Sugar Alcohol Dehydrogenases / Q000502:physiology*
D007093:Imidazoles; D048289:Imidazolidines; D005985:Glyceraldehyde; D013401:Sugar Alcohol Dehydrogenases; D007064:L-Iditol 2-Dehydrogenase; D000449:Aldehyde Reductase; C026411:sorbinil